Aim: Whether clusterin/apolipoprotein J is antiatherogenic or proatherogenic is controversial. We reported that clusterin was markedly induced in media and neointima after vascular injury and that reduced clusterin expression reduced the proliferation of vascular smooth muscle cells (VSMCs), which induced G1 arrest via p53 and p21. The purpose of this study was to investigate the physiological function of clusterin in atherosclerosis using double-knockout mice (D-KO) of apolipoprotein E-deficient mice (apoE-KO) and clusterin-deficient mice (CLU-KO). 
matory disease 2) . Oxidized low-density lipoprotein is believed to play a key role in cellular dysfunction, as well as cholesterol accumulation and subsequent foam-cell transformation in macrophages and phenotypically modulated vascular smooth muscle cells (VSMCs) 3, 4) ; however, the precise mechanisms that evoke inflammatory processes in plaque formation and progression remain incompletely defined.
Clusterin (also designated apolipoprotein J) is an extracellular, highly conserved, and heavily glycosylated disulfide-linked heterodimer with an apparent molecular mass of 70 kDa 5) . Clusterin is constitutively expressed in almost all mammalian tissues by different cell types, including epithelial and specific neuronal
Introduction
Atherosclerosis is a progressive disease characterized by the accumulation of lipids and fibrous elements in the large arteries and constitutes the single most important contributor to the growing burden of cardiovascular disease 1) . Atherosclerosis is an inflam-cells. Furthermore, clusterin is found in all body fluids, including plasma, seminal plasma, milk, urine, and cerebrospinal fluid 5, 6) . The wide distribution and sequence conservation of clusterin suggest that this protein performs functions of fundamental biological importance. It is involved in numerous physiological processes important for carcinogenesis and tumor growth, including apoptotic cell death, cell cycle regulation, DNA repair, cell adhesion, tissue remodeling, lipid transportation, membrane recycling, and immune system regulation 7) . Furthermore, the expression of clusterin is upregulated in acute myocardial infarction, atherosclerosis 8) , myocarditis 9) , Alzheimer's disease 10) , several cancers 11) , oxidative stress, heat shock 12) , and after injury in general 6) . We reported that clusterin was markedly induced in media and neointima after vascular injury and that the expression of clusterin stimulated the proliferation and migration of cultured VSMCs in vitro 13) . In addition, Millis et al. reported that clusterin regulates VSMC nodule formation and migration 14) . Moreover, clusterin antisense was reported to inhibit the proliferation of cultured VSMCs obtained from neointima after ballooning in vitro 15) . Recently, we reported that reduced clusterin expression reduced the proliferation of VSMCs and induced G1 arrest via p53 and p21 16) . Although clusterin is expressed in atherosclerosis lesions, it is not clear whether it is antiatherogenic or proatherogenic.
The purpose of this study was to investigate the physiological function of clusterin in atherosclerosis using double-knockout mice (D-KO) of apolipoprotein E-deficient mice (apoE-KO) and clusterin-deficient mice (CLU-KO).
Materials and Methods

Generation of CLU / /apoE / Double-Knockout Mice (D-KO)
We used apoE-KO mice with a C57BL/6 background that were donated by Dr. Jan L. Bresslow (Rockefeller University) and CLU-KO mice with a C57BL/6 background. CLU-KO mice were as described by McLaughlin et al. 17) . Unperturbed CLU-KO mice showed a minimal phenotype, including atherosclerosis and inflammation. ApoE-KO mice were crossed with CLU-KO mice and heterozygous knockout mice were crossed until homozygous double-knockout (D-KO) mice were obtained. Genotypes for apoE and clusterin were determined by polymerase chain reaction (PCR) amplification of DNA isolated from the tail. Mice were fed a standard diet and water was available ad libitum. All animal procedures were 
Genotyping by Polymerase Chain Reaction
Clusterin genotyping was performed by PCR analysis using three primers obtained from SigmaAldrich Japan (Tokyo, Japan) that amplified both wild-type and mutant alleles in the same reaction. These were: SHF-3 (5'-ACGATGTGGAAGGATGT-GGAAGATGAACATG-3') forward primer, recognizing both mutant and wild-type alleles and corresponding to genomic sequences near the 5' end of the short homology fragment; apoJKO-R2 (5'-TGGTGAT-GGGGCTCTAGTCACCTCCCACTTC-3'), reverse wild-type primer complementary to sequences just 3' to the deleted first exon; and PGK-2 (5'-CTGCTA-AAGCGCATGCTCCAGACTGCCTTG-3'), reverse knockout primer corresponding to sequences in the promoter region of the hypoxanthine phosphoribosyl transferase (HPRT) cassette. PCR for wild-type (500 bp) and mutant (540 bp) alleles was performed with cycles consisting of 3 minutes at 94 , 45 seconds at 52 , and 45 seconds at 72 17) . Apolipoprotein E genotyping used the following primers (Sigma-Aldrich Japan): antisense, 5'-GCCTA GCCGAGGGAGAGCCG-3' and sense, 5'-GCCG-CCCCGACTGCATCT-3'. Resultant wild-type and deficient allele bands were 155 bp and 245 bp, respectively. PCR was performed with 35 cycles consisting of 3 minutes at 94 , 40 seconds at 68 , and 2 minutes at 72 .
Tissue Preparation and Lesion Assessment
Male double-homozygous (CLU / /apoE / ; D-KO) mice and male apoE knockout (CLU / /apoE / ; apoE-KO) mice were compared in this study. At the age of 20 weeks, mice were anesthetized with pentobarbital (80 g/kg body weight, intraperitoneally) and fasting blood was drawn from the left ventricle of the anesthetized mice. Plasma total cholesterol, triglyceride, and HDL cholesterol levels were measured with an enzymatic kit (Kainos, Tokyo, Japan).
After blood drawing, mice were perfused with phosphate-buffered saline (pH 7.4) followed by 10% neutral-buffered formalin through a catheter placed in the left ventricle. The heart with the aortic root was fixed in 10% neutral-buffered formalin, embedded in OCT, and frozen at 80 . Frozen sections were cut into 10-m sections and fixed to glass slides. The slides were stained with oil red O. All sections were examined under a microscope; the lipid staining of the aortic root in the histological sections was quantitated 18) .
Immunohistochemical Analysis
The heart with the aortic root was also paraffinembedded and stored at room temperature. Immunohistochemical staining was carried out on paraffinembedded sections as described previously 19) . After deparaffinization and hydration of specimens, the endogenous peroxidase activity was blocked and the specimens were fixed by immersion in 0.3% H2O2 in methanol for 20 minutes. Immunohistochemical staining was performed with a rabbit polyclonal antibody against human Egr-1 (Santa Cruz Biotechnology, Santa Cruz, CA) using the labeled streptavidin biotin complex method (Simple-stain MAX-PO kit, Nichirei, Tokyo, Japan). After blocking with 10% rabbit or goat serum, slides were incubated overnight with a primary antibody at 4 in a moisture chamber. Slides were washed with Tris-buffered saline and incubated with a biotinylated secondary antibody at room temperature for 30 minutes. After washing with Tris-buffered saline, slides were incubated with streptavidin at room temperature for 30 minutes and visualized with 3,3'-diaminobenzidine.
Western Blot Analysis
Protein was extracted from the aorta of apoE-KO or D-KO mice using the Protein and RNA Isolation System (Ambion Inc., Austin, TX). Insoluble matter was removed by centrifugation and the protein concentration was measured by a bicinchoninic acid assay (PIERCE Biotechnology Inc., Rockford, IL). Western blotting was performed with the NuPAGE TM Electrophoresis System (Invitrogen, Carlsbad, CA) as reported previously 20) . Briefly, 10-g protein samples were resuspended in reduced sample buffer and then electrophoresed on a 4-12% Bis-Tris gel (Invitrogen, Carlsbad, CA) with 3-(N-morpholino) propanesulfonic acid (MOPS) running buffer and blotted on to a nitrocellulose membrane. The protein sample was then sequentially probed with a rabbit polyclonal antibody against human clusterin, ERK1, Egr-1, TNF-, and actin (Santa Cruz Biotechnology). Horseradish peroxidase-conjugated donkey anti-rabbit antibody (Santa Cruz Biotechnology) was then added and the secondary antibody was detected by autoradiography using enhanced chemiluminescence (ECL Plus; GE Healthcare UK Ltd., Little Chalfont, UK). Densitometric analysis was performed to quantitate Egr-1, TNF-, and actin protein using NIH imaging software. Actin protein was used as a reference for quantitation of Egr-1 and TNF-protein.
Cell Experiments
Primary VSMCs were explanted from the medial layer of each apoE-KO or D-KO mouse aorta as described previously 21) . They were cultured in 75-cm 2 flasks for continuous growth at 37 in a humidified atmosphere of 95% air and 5% CO2 with medium changes every 3 days. The growth medium consisted of Dulbecco's modified Eagle's Medium (DMEM) (Invitrogen) supplemented with 10% fetal bovine serum (FBS; SAFC Biosciences, Wicklow, Ireland), 100 units/mL penicillin, and 100 mg/mL streptomycin (Invitrogen). The VSMCs used for experiments were from the third to seventh passages. At 48 hours of incubation, the cells were harvested by trypsinization and counted in a CDA-500 Particle Analyzer (SYSMEX CORPORATION, Hyogo, Japan). At 48 hours of incubation, cytoplasmic and nuclear proteins were extracted from cultured VSMCs using the Protein and RNA Isolation System. Peritoneal macrophages were recruited and collected from the peritoneal cavities of mice. We injected 5 mL of ice-cold PBS into the peritoneal cavity and harvested by lavage of the peritoneal cavity. The cells from 5 mice were incubated in DMEM supplemented with 10% FBS in 75-cm 2 flasks at 37 in a humidified atmosphere of 95% air and 5% CO2 for 12 hours. Then, 4 hours after adding lipopolysaccharide (LPS; 25 ng/mL), cytoplasmic and nuclear proteins were extracted from cultured macrophages using the Protein and RNA Isolation System. We examined the expression levels of Egr-1 and TNF-in VSMCs and macrophages as described in the section on Western blot analysis.
Statistical Analysis
All calculated data are presented as the mean SD. Statistical significance was evaluated using the unpaired Student's t -test for comparisons between two groups. A probability value of p 0.05 was considered statistically significant.
Results
Body Weight and Lipid Concentrations
At 20 weeks old, there were no significant differences in body weight (apoE-KO: 27. Fig. 1D ) concentrations between the apoE-KO and D-KO mice. In addition, there were no differences in blood sugar levels, blood cell counts and anatomical subjects between apoE-KO and D-KO mice.
Atherosclerotic Lesions
We analyzed atherosclerotic lesions in the aortic roots. Fig. 2B ).
Immunohistochemistry
We performed immunohistochemical staining using a primary antibody against Egr-1, which is an atherogenic factor and a promoter of clusterin. The expression of Egr-1 in atherosclerotic lesions of D-KO mice was lower than that of apoE-KO mice (Fig. 3A) .
Western Blotting
We isolated protein from the aortas of apoE-KO or D-KO mice at 20 weeks old and used it for Western blotting. We confirmed that clusterin was expressed in atherosclerotic aorta of apoE-KO mice and was not detected in D-KO mice. Densitometric analysis of Western blotting demonstrated that the expression levels of ERK, Egr-1, and TNF-in D-KO mice were significantly lower than those in apoE-KO mice (ERK: apoE-KO 1. Fig. 3B ). These results suggested that clusterin deficiency reduced the expression of the Egr-1/TNF-pathway.
Cell Experiment
Cultured VSMCs were explanted from the thoracic aortas obtained from apoE-KO or D-KO mice. Fig. 4B, C) .
Furthermore, we analyzed the expression levels of 
Discussion
For the first time, we demonstrated that the atherosclerotic lesion of D-KO mice was significantly smaller than that of apoE-KO mice. Moreover, the loss of clusterin reduced the expression of Egr-1 and TNF-in the atherosclerotic lesion, and cultured VSMCs and macrophages. These results suggested that clusterin is an atherogenic factor.
Clusterin plays a dual role as a tumor suppressor and a tumor promoter. This diverse set of functions can be attributed to the existence of two alternatively spliced forms, secretory clusterin (sCLU) and nuclear clusterin (nCLU) 22) . The sCLU form is cytoprotective. Recently, Kim et al. reported that sCLU inhibited the proliferation and migration of VSMCs 23) . In contrast, nCLU migrates to the nucleus upon cytotoxic stress to trigger cell death and interacts with the DNA doublestrand break repair antigen Ku70, blocking its function and causing cell death 24) . In this study, Western blotting demonstrated that nCLU, a 49-kDa protein expressed in the atherosclerosis of apoE-KO mice, and reduced nCLU expression reduced the atherosclerotic lesions of apoE-KO mice.
Egr-1 is a promoter of clusterin and contributes to the pathogenesis of atherosclerotic lesions 25) . Subsequent studies comparing Egr-1 protein expression in cells derived from the human atherosclerotic lesion and media at low passage revealed greater expression in lesions 26) . The lesion area in mice deficient in both Egr-1 and apoE is markedly reduced compared with that in mice lacking apoE alone 27) . Egr-1 is also found in inflammatory cells of vascular lesions. For example, Egr-1 is expressed in CD68 macrophages of aortic atherosclerotic lesions in fructose-fed low-density lipoprotein receptor-deficient mice 28) . Thus, Egr-1 is found in several cell types within atherosclerotic lesions and is a factor required in atherogenesis. TNF-, IL-2, MCP-1, and ICAM-1 are Egr-1 target genes 29) . We demonstrated that loss of clusterin reduced the activation of Egr-1/TNF-in VSMCs and macrophages and reduced the atherosclerotic lesions.
Clusterin exerts a feed-forward loop including ERK activation, which leads to the up-regulation of Egr-1 and clusterin 30) . We confirmed that the expression of ERK and Egr-1 was down-regulated in atherosclerotic lesions of D-KO mice; therefore, we think that the down-regulation of clusterin leads to the reduction of Egr-1 via down-regulation of ERK.
We demonstrated that the proliferation of VSMC in D-KO was reduced. In addition, we showed the down-regulation of Egr-1 and TNF-of D-KO VSMCs. These results suggest that clusterin deficiency down-regulates the expression of Egr-1 and TNF-, which leads to the suppression of VSMC proliferation.
Macrophages play an important role in atherosclerosis. We demonstrated that the expression of Egr-1 and TNF-was down-regulated in macrophages obtained from D-KO mice; therefore, the reduction of Egr-1 and TNF-expression in macrophages may also lead to the reduction of atherosclerosis in D-KO mice. In addition, clusterin is reported to inhibit the migration and adhesion of human umbilical vein endothelial cells 31) . Clusterin is identical to apolipoprorein J; however, there were no significant differences in total cholesterol, HDL cholesterol, and triglyceride levels between apoE-KO and D-KO. Therefore, we think that clusterin deficiency did not reduce atherosclerosis via lipoprotein metabolism in this study.
Intravenous infusion of the antisense oligonucleotide of clusterin, which is called OGX-011, has been approved for clinical phase trials in prostate cancer. OGX-011 may be used for the prevention or regression of atherosclerosis.
In conclusion, loss of clusterin strongly suppressed apoE-KO induced atherosclerotic lesions at a step prior to the expression of Egr-1 and TNF-, suggesting that clusterin is a candidate for an antiatherogenic target.
